Target Price | $24.33 |
Price | $13.30 |
Potential |
82.96%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Silverback Therapeutics 2025 .
The average Silverback Therapeutics target price is $24.33.
This is
82.96%
register free of charge
$30.00
125.56%
register free of charge
$21.00
57.89%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Silverback Therapeutics to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Silverback Therapeutics stock has an average upside potential 2025 of
82.96%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.03 | 4.13 |
97.73% | 13,650.00% | |
Net Margin | -184,186.00% | -1,504.04% |
2,782.76% | 99.18% |
4 Analysts have issued a sales forecast Silverback Therapeutics 2024 . The average Silverback Therapeutics sales estimate is
This results in the following potential growth metrics:
2 Silverback Therapeutics Analysts have issued a net profit forecast 2024. The average Silverback Therapeutics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.57 | -0.64 |
34.48% | 12.28% | |
P/E | negative | |
EV/Sales | 259.57 |
2 Analysts have issued a Silverback Therapeutics forecast for earnings per share. The average Silverback Therapeutics <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Silverback Therapeutics stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Silverback Therapeutics...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.